Previous Close | 352.23 |
Open | 354.02 |
Bid | 0.00 x 900 |
Ask | 0.00 x 800 |
Day's Range | 352.62 - 355.92 |
52 Week Range | 249.98 - 361.41 |
Volume | |
Avg. Volume | 1,310,650 |
Market Cap | 134.644B |
Beta (5Y Monthly) | 0.90 |
PE Ratio (TTM) | 42.92 |
EPS (TTM) | 8.25 |
Earnings Date | Apr 29, 2024 - May 03, 2024 |
Forward Dividend & Yield | 3.20 (0.90%) |
Ex-Dividend Date | Mar 27, 2024 |
1y Target Est | 362.37 |
Subscribe to Yahoo Finance Plus to view Fair Value for SYK
Investors are optimistic about Chemed (CHE) on strong performance across the VITAS and Roto-Rooter segments.
Labcorp's (LH) new research shows how biomarker testing can help close testing gaps and guide tailored therapy for patients with epithelial ovarian cancer.
Boston Scientific (BSX) is consistently registering fast recovery within its MedSurg segment in the post-pandemic period.